Thursday, July 24, 2025

Lunit & Microsoft Partner to Advance AI Cancer Diagnosis

Related stories

Gathr.ai Launches Data Warehouse Intelligence Feature

Gathr.ai has introduced Data Warehouse Intelligence, a powerful new...

AWS & Meta Partner to Accelerate AI Innovation

Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company,...

Daylight Launches AI-Driven MDR with Human Expertise

Daylight Security announces that it has emerged from stealth...

OpenText Launches Cloud Editions 25.3 to Advance AI, Cloud, Security

OpenText has unveiled its latest release, Cloud Editions (CE)...

Dante Omics AI Brings Genomics to the AI Era With GPUs

Advanced NVIDIA GPU Integration Transforms Genome and Multiomics Alignment,...
spot_imgspot_img

Lunit, a leading provider of AI for cancer diagnostics and therapeutics, announced a collaboration with Microsoft to accelerate the delivery of AI-powered healthcare solutions. In conjunction with their recent acquisition of Volpara, a Microsoft Industry Health Certified Partner, this collaboration will give health professionals globally access to tools that will assist in the detection of cancer.

This underscores Lunit’s long-term vision to move beyond standalone AI tools—toward building integrated solutions that align with real-world clinical practice. By joining forces with Microsoft, Lunit is poised to deliver scalable technologies that not only streamline radiology workflows but also drive measurable improvements in diagnostic consistency and patient care across diverse healthcare settings.

This marks a significant milestone in Lunit’s mission to expand access to AI tools, particularly in the U.S. market, by leveraging Microsoft Azure’s global cloud infrastructure and deep expertise in healthcare-focused AI technologies.

Key highlights of the collaboration include:

  • Co-Development of AI Model Customization Service on Azure: Lunit and Microsoft collaborate to develop a service that allows fine-tuning of AI models using site-specific clinical data from each customer. This approach helps mitigate cross-site model performance variability—one of the key challenges in deploying AI in real-world clinical environments—and ensures more reliable, tailored outcomes in diverse clinical settings.
  • Leveraging Microsoft’s AI Platform for Innovative Workflow Solutions: Moving beyond point solutions, Lunit will leverage Microsoft’s agentic AI frameworks—designed to support intelligent task automation—to develop end-to-end workflow automation tools. These solutions aim to simplify clinical decision-making and enhance operational efficiency across the care continuum.

Also Read: Quiver Bioscience Gets Funding to Boost CNS Drug Platform

“For AI to truly make an impact in healthcare, it must be accessible, scalable, and seamlessly integrated into clinical practice,” said Brandon Suh, CEO of Lunit. “Our collaboration with Microsoft enables us to bring our AI to more providers through trusted platforms like Microsoft Azure, helping us expand access in the U.S. and beyond. This collaboration brings us one step closer to delivering high-quality, consistent care through AI—at scale.”

“With Microsoft Azure, we are shaping an ecosystem that supports partners like Lunit in delivering scalable AI innovations,” said Naveen Valluri, General Manager, Health and Life Sciences Data and AI at Microsoft. “By combining our infrastructure with clinical-grade AI developed in close collaboration with leaders like Lunit, we’re accelerating the development of intelligent, integrated solutions for radiology and beyond.”

Source: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img